logo
Soorty Expands Use of Haelixa's DNA Tracers

Soorty Expands Use of Haelixa's DNA Tracers

Yahoo4 days ago
Soorty is expanding its partnership with Swiss traceability technology company Haelixa.
The mill announced it is integrating Haelixa's DNA markers to Second Life, Soorty's recycled cotton initiative designed to increase resource efficiency and reduce the environmental footprint of the denim supply chain.
More from Sourcing Journal
Mango Supports Regen Cotton Farmers with Materra Collection
Take Our Traceability Survey!
What's the Status on Digital Product Passport Implementation?
The invisible, non-toxic liquid-based tracers are sprayed directly to post-consumer textile waste before mechanical shredding. These markers withstand spinning, dyeing and garment manufacturing, enabling verification at every stage of production.
The partnership also gives Soorty's brand partners the option to use a 'Marked & Traced by Haelixa' label on garments made with Second Life fiber, including a scannable QR code that links to a dedicated landing page. Soorty says this enables brands to tell the product's sourcing story in detail, while giving end consumers direct access to verified data about fiber origin, processing stages, and supply chain transparency.
'Our partnership with Soorty shows how physical traceability builds confidence in circular claims and meets the rising demand for credible, transparent sourcing,' said Dr. Gediminas Mikutis, Haelixa co-founder and CTO.
Providing supply chain visibility and brand accountability have been long-time priorities for the Denim Deal members. In 2022, the mill began working with Haelixa to test the integration of the DNA marker technology within its recycled cotton workflow. It was limited in scope, applied strategically based on specific customer demands, but successful in proving that the markers could reliably survive the full manufacturing process and provide verified traceability.
Since then, Soorty has expanded the use of Haelixa's DNA tracers beyond that initial trial.
'Our long-standing partnership with Haelixa continues to advance Soorty's commitment to circular fashion,' said Eda Dikmen, senior marketing and communications manager at Soorty. 'By enabling reliable authentication and traceability throughout the lifecycle of the product—from our mills to the final garment, which could be traced at any time—we're solidifying our claims while also empowering our brand partners to meet their targets with proof. This shared transparency fosters deeper trust and genuinely equips end customers to make informed decisions.'
As one of Pakistan's largest vertically integrated denim manufacturers, this partnership with Haelixa presents a significant opportunity to drive meaningful impact in the field of traceable denim.
Soorty launched Second Life in 2022. The textile-to-textile recycling operation is supported by Soorty's large-scale vertical set-up, expertise in spinning short regenerative fibers and access to Pakistan's vast feedstock of post-consumer and post-industrial waste.
Dikmen said Second Life is establishing new benchmarks for closed-loop production, and the scale of its impact is both substantial and growing. In addition to being used for Soorty fabrics, Second Life recycled cotton is available to other mills and spinners. In 2023, the mill diverted 10.8 million kg of used garments from landfills, producing 5.4 million kg of post-consumer waste fiber with a recovery rate of almost 48-50 percent from garments.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

MVV Energie Third Quarter 2025 Earnings: EPS: €0.36 (vs €0.38 in 3Q 2024)
MVV Energie Third Quarter 2025 Earnings: EPS: €0.36 (vs €0.38 in 3Q 2024)

Yahoo

time6 minutes ago

  • Yahoo

MVV Energie Third Quarter 2025 Earnings: EPS: €0.36 (vs €0.38 in 3Q 2024)

Explore MVV Energie's Fair Values from the Community and select yours MVV Energie (ETR:MVV1) Third Quarter 2025 Results Key Financial Results Revenue: €1.35b (up 3.4% from 3Q 2024). Net income: €23.7m (down 4.4% from 3Q 2024). Profit margin: 1.7% (down from 1.9% in 3Q 2024). The decrease in margin was driven by higher expenses. EPS: €0.36 (down from €0.38 in 3Q 2024). We've found 21 US stocks that are forecast to pay a dividend yield of over 6% next year. See the full list for free. All figures shown in the chart above are for the trailing 12 month (TTM) period MVV Energie's share price is broadly unchanged from a week ago. Risk Analysis Before we wrap up, we've discovered 2 warning signs for MVV Energie (1 is significant!) that you should be aware of. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

PolyPeptide Group First Half 2025 Earnings: Revenues Beat Expectations, EPS Lags
PolyPeptide Group First Half 2025 Earnings: Revenues Beat Expectations, EPS Lags

Yahoo

time6 minutes ago

  • Yahoo

PolyPeptide Group First Half 2025 Earnings: Revenues Beat Expectations, EPS Lags

Explore PolyPeptide Group's Fair Values from the Community and select yours PolyPeptide Group (VTX:PPGN) First Half 2025 Results Key Financial Results Revenue: €167.1m (up 24% from 1H 2024). Net loss: €26.5m (loss widened by 133% from 1H 2024). €0.80 loss per share (further deteriorated from €0.35 loss in 1H 2024). Trump has pledged to "unleash" American oil and gas and these 15 US stocks have developments that are poised to benefit. All figures shown in the chart above are for the trailing 12 month (TTM) period PolyPeptide Group Revenues Beat Expectations, EPS Falls Short Revenue exceeded analyst estimates by 12%. Earnings per share (EPS) missed analyst estimates by 40%. Looking ahead, revenue is forecast to grow 14% p.a. on average during the next 3 years, compared to a 11% growth forecast for the Life Sciences industry in Switzerland. Performance of the Swiss Life Sciences industry. The company's shares are up 25% from a week ago. Risk Analysis Before we wrap up, we've discovered 1 warning sign for PolyPeptide Group that you should be aware of. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Fehler beim Abrufen der Daten Melden Sie sich an, um Ihr Portfolio aufzurufen. Fehler beim Abrufen der Daten Fehler beim Abrufen der Daten Fehler beim Abrufen der Daten Fehler beim Abrufen der Daten

Fastned B.V First Half 2025 Earnings: €0.94 loss per share (vs €0.59 loss in 1H 2024)
Fastned B.V First Half 2025 Earnings: €0.94 loss per share (vs €0.59 loss in 1H 2024)

Yahoo

time6 minutes ago

  • Yahoo

Fastned B.V First Half 2025 Earnings: €0.94 loss per share (vs €0.59 loss in 1H 2024)

Explore Fastned B.V's Fair Values from the Community and select yours Fastned B.V (AMS:FAST) First Half 2025 Results Key Financial Results Revenue: €58.6m (up 55% from 1H 2024). Net loss: €18.3m (loss widened by 60% from 1H 2024). €0.94 loss per share (further deteriorated from €0.59 loss in 1H 2024). AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early. All figures shown in the chart above are for the trailing 12 month (TTM) period Fastned B.V Earnings Insights Looking ahead, revenue is forecast to grow 30% p.a. on average during the next 3 years, compared to a 5.5% growth forecast for the Specialty Retail industry in Europe. Performance of the market in the Netherlands. The company's shares are up 3.2% from a week ago. Risk Analysis Before you take the next step you should know about the 1 warning sign for Fastned B.V that we have uncovered. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store